Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth

The New York Times – Business:

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too.

This post first appeared in The New York Times – Business. Read the original article.